Research Advances in Add-on Treatment for Negative Symptoms and Cognitive Dysfunction in Schizophrenia

Ranran Li,Gangrui Hei,Ye Yang,Renrong Wu,Jingping Zhao
DOI: https://doi.org/10.11817/j.issn.1672-7347.2020.190556
2020-01-01
Abstract:Antipsychotic medication is the primary treatment for schizophrenia, which is effective on ameliorating positive symptoms and can reduce the risk of recurrence, but it has limited efficacy for negative symptoms and cognitive dysfunction. The negative symptoms and cognitive dysfunction seriously affects the life quality and social function for the patients with schizophrenia. Currently, there is plenty evidence that antipsychotic drugs combined with adjuvant therapy drugs can effectively improve the negative symptoms and cognitive dysfunction. These drugs include anti-oxidants, nicotinic acetylcholine receptors and neuro-inflammatory drugs (anti-inflammatory drugs, minocycline), which show potential clinical effects.
What problem does this paper attempt to address?